ID   NDKB_HUMAN              Reviewed;         152 AA.
AC   P22392; A8MWA3; Q1WM23; Q6LCT6;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   10-MAY-2017, entry version 205.
DE   RecName: Full=Nucleoside diphosphate kinase B;
DE            Short=NDK B;
DE            Short=NDP kinase B;
DE            EC=2.7.4.6;
DE   AltName: Full=C-myc purine-binding transcription factor PUF;
DE   AltName: Full=Histidine protein kinase NDKB;
DE            EC=2.7.13.3;
DE   AltName: Full=nm23-H2;
GN   Name=NME2; Synonyms=NM23B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1988104;
RA   Stahl J.A., Leone A., Rosengard A.M., Porter L., Liotta L.A.,
RA   Steeg P.S., King C.R.;
RT   "Identification of a second human nm23 gene, nm23-H2.";
RL   Cancer Res. 51:445-449(1991).
RN   [2]
RP   PROTEIN SEQUENCE (ISOFORM 1), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=1851158;
RA   Gilles A.-M., Presecan E., Vonica A., Lascu I.;
RT   "Nucleoside diphosphate kinase from human erythrocytes. Structural
RT   characterization of the two polypeptide chains responsible for
RT   heterogeneity of the hexameric enzyme.";
RL   J. Biol. Chem. 266:8784-8789(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8392752; DOI=10.1126/science.8392752;
RA   Postel E.H., Berberich S.J., Flint S.J., Ferrone C.A.;
RT   "Human c-myc transcription factor PuF identified as nm23-H2 nucleoside
RT   diphosphate kinase, a candidate suppressor of tumor metastasis.";
RL   Science 261:478-480(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Neuroblastoma;
RX   PubMed=16442775; DOI=10.1016/j.ygeno.2005.11.004;
RA   Valentijn L.J., Koster J., Versteeg R.;
RT   "Read-through transcript from NM23-H1 into the neighboring NM23-H2
RT   gene encodes a novel protein, NM23-LV.";
RL   Genomics 87:483-489(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-18.
RX   PubMed=7488060; DOI=10.1006/bbrc.1995.2550;
RA   Seifert M., Seib T., Engel M., Dooley S., Welter C.;
RT   "Characterization of the human nm23-H2 promoter region and
RT   localization of the microsatellite D17S396.";
RL   Biochem. Biophys. Res. Commun. 215:910-914(1995).
RN   [8]
RP   INTERACTION WITH ITGB1BP1, AND SUBCELLULAR LOCATION.
RX   PubMed=11919189; DOI=10.1074/jbc.M200200200;
RA   Fournier H.N., Dupe-Manet S., Bouvard D., Lacombe M.L., Marie C.,
RA   Block M.R., Albiges-Rizo C.;
RT   "Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha)
RT   interacts directly with the metastasis suppressor nm23-H2, and both
RT   proteins are targeted to newly formed cell adhesion sites upon
RT   integrin engagement.";
RL   J. Biol. Chem. 277:20895-20902(2002).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH AKAP13.
RX   PubMed=15249197; DOI=10.1016/j.bbrc.2004.06.067;
RA   Iwashita S., Fujii M., Mukai H., Ono Y., Miyamoto M.;
RT   "Lbc proto-oncogene product binds to and could be negatively regulated
RT   by metastasis suppressor nm23-H2.";
RL   Biochem. Biophys. Res. Commun. 320:1063-1068(2004).
RN   [10]
RP   FUNCTION AS HISTIDINE PROTEIN KINASE.
RX   PubMed=20946858; DOI=10.1016/S0076-6879(10)71020-X;
RA   Wieland T., Hippe H.J., Ludwig K., Zhou X.B., Korth M., Klumpp S.;
RT   "Reversible histidine phosphorylation in mammalian cells: a teeter-
RT   totter formed by nucleoside diphosphate kinase and protein histidine
RT   phosphatase 1.";
RL   Methods Enzymol. 471:379-402(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   PubMed=7658474; DOI=10.1006/jmbi.1995.0457;
RA   Webb P.A., Perisic O., Mendola C.E., Backer J.M., Williams R.L.;
RT   "The crystal structure of a human nucleoside diphosphate kinase, NM23-
RT   H2.";
RL   J. Mol. Biol. 251:574-587(1995).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2 ANGSTROMS).
RX   PubMed=8747457; DOI=10.1016/S0969-2126(01)00268-4;
RA   Morera S., Lacombe M.-L., Xu Y., Lebras G., Janin J.;
RT   "X-ray structure of human nucleoside diphosphate kinase B complexed
RT   with GDP at 2-A resolution.";
RL   Structure 3:1307-1314(1995).
CC   -!- FUNCTION: Major role in the synthesis of nucleoside triphosphates
CC       other than ATP. Negatively regulates Rho activity by interacting
CC       with AKAP13/LBC. Acts as a transcriptional activator of the MYC
CC       gene; binds DNA non-specifically (PubMed:8392752). Exhibits
CC       histidine protein kinase activity. {ECO:0000269|PubMed:15249197,
CC       ECO:0000269|PubMed:20946858, ECO:0000269|PubMed:8392752}.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + protein L-histidine = ADP + protein N-
CC       phospho-L-histidine.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Hexamer of two different chains: A and B (A6, A5B, A4B2,
CC       A3B3, A2B4, AB5, B6). Interacts with CAPN8 (By similarity).
CC       Interacts with AKAP13. Interacts ITGB1BP1 (via C-terminal domain
CC       region). {ECO:0000250, ECO:0000269|PubMed:11919189,
CC       ECO:0000269|PubMed:15249197, ECO:0000269|PubMed:1851158}.
CC   -!- INTERACTION:
CC       O14713-1:ITGB1BP1; NbExp=7; IntAct=EBI-713693, EBI-2127367;
CC       P15531:NME1; NbExp=2; IntAct=EBI-713693, EBI-741141;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16442775}.
CC       Nucleus {ECO:0000269|PubMed:16442775}. Cell projection,
CC       lamellipodium {ECO:0000269|PubMed:11919189}. Cell projection,
CC       ruffle {ECO:0000269|PubMed:11919189}. Note=Isoform 3 is mainly
CC       cytoplasmic and isoform 1 and isoform 3 are excluded from the
CC       nucleolus. Colocalizes with ITGB1 and ITGB1BP1 at the edge or
CC       peripheral ruffles and lamellipodia during the early stages of
CC       cell spreading on fibronectin or collagen but not on vitronectin
CC       or laminin substrates. {ECO:0000269|PubMed:11919189,
CC       ECO:0000269|PubMed:16442775}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NM23-H2;
CC         IsoId=P22392-1; Sequence=Displayed;
CC       Name=3; Synonyms=NM23-LV;
CC         IsoId=P22392-2; Sequence=VSP_036708;
CC         Note=Based on a naturally occurring readthrough transcript which
CC         produces an NME1-NME2 fusion protein. {ECO:0000250};
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 3 are ubiquitously
CC       expressed. {ECO:0000269|PubMed:16442775}.
CC   -!- SIMILARITY: Belongs to the NDK family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X58965; CAB37870.1; -; mRNA.
DR   EMBL; M36981; AAA36369.1; -; mRNA.
DR   EMBL; L16785; AAA60228.1; -; mRNA.
DR   EMBL; DQ109675; AAZ82097.1; -; mRNA.
DR   EMBL; AC005839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002476; AAH02476.1; -; mRNA.
DR   EMBL; BC133029; AAI33030.1; -; mRNA.
DR   EMBL; BC133031; AAI33032.1; -; mRNA.
DR   EMBL; U29200; AAA86745.1; -; Genomic_DNA.
DR   CCDS; CCDS11580.1; -. [P22392-1]
DR   PIR; A49798; A49798.
DR   RefSeq; NP_001018146.1; NM_001018136.2. [P22392-2]
DR   RefSeq; NP_001018147.1; NM_001018137.2. [P22392-1]
DR   RefSeq; NP_001018148.1; NM_001018138.1. [P22392-1]
DR   RefSeq; NP_001018149.1; NM_001018139.2. [P22392-1]
DR   RefSeq; NP_002503.1; NM_002512.3. [P22392-1]
DR   UniGene; Hs.463456; -.
DR   PDB; 1NSK; X-ray; 2.80 A; L/N/O/R/T/U=1-152.
DR   PDB; 1NUE; X-ray; 2.00 A; A/B/C/D/E/F=2-152.
DR   PDB; 3BBB; X-ray; 1.30 A; A/B/C/D/E/F=2-152.
DR   PDB; 3BBC; X-ray; 1.70 A; A/B/C/D/E/F=2-152.
DR   PDB; 3BBF; X-ray; 1.70 A; A/B/C/D/E/F=2-152.
DR   PDBsum; 1NSK; -.
DR   PDBsum; 1NUE; -.
DR   PDBsum; 3BBB; -.
DR   PDBsum; 3BBC; -.
DR   PDBsum; 3BBF; -.
DR   ProteinModelPortal; P22392; -.
DR   SMR; P22392; -.
DR   BioGrid; 110895; 83.
DR   BioGrid; 576341; 45.
DR   DIP; DIP-50179N; -.
DR   IntAct; P22392; 20.
DR   MINT; MINT-1429922; -.
DR   STRING; 9606.ENSP00000376886; -.
DR   ChEMBL; CHEMBL2160; -.
DR   DrugBank; DB00718; Adefovir Dipivoxil.
DR   DrugBank; DB04315; Guanosine-5'-Diphosphate.
DR   DrugBank; DB00709; Lamivudine.
DR   DrugBank; DB00300; Tenofovir.
DR   iPTMnet; P22392; -.
DR   PhosphoSitePlus; P22392; -.
DR   SwissPalm; P22392; -.
DR   BioMuta; NME2; -.
DR   DMDM; 127983; -.
DR   DOSAC-COBS-2DPAGE; P22392; -.
DR   OGP; P22392; -.
DR   UCD-2DPAGE; P22392; -.
DR   EPD; P22392; -.
DR   PaxDb; P22392; -.
DR   PeptideAtlas; P22392; -.
DR   PRIDE; P22392; -.
DR   TopDownProteomics; P22392-1; -. [P22392-1]
DR   TopDownProteomics; P22392-2; -. [P22392-2]
DR   DNASU; 4831; -.
DR   DNASU; 654364; -.
DR   Ensembl; ENST00000393190; ENSP00000376886; ENSG00000243678. [P22392-1]
DR   Ensembl; ENST00000503064; ENSP00000426901; ENSG00000243678. [P22392-1]
DR   Ensembl; ENST00000512737; ENSP00000421064; ENSG00000243678. [P22392-1]
DR   Ensembl; ENST00000513177; ENSP00000425581; ENSG00000243678. [P22392-1]
DR   Ensembl; ENST00000514264; ENSP00000426976; ENSG00000243678. [P22392-1]
DR   GeneID; 4831; -.
DR   GeneID; 654364; -.
DR   KEGG; hsa:4831; -.
DR   KEGG; hsa:654364; -.
DR   UCSC; uc002itj.4; human. [P22392-1]
DR   CTD; 4831; -.
DR   CTD; 654364; -.
DR   DisGeNET; 4831; -.
DR   GeneCards; NME2; -.
DR   HGNC; HGNC:7850; NME2.
DR   HPA; CAB002169; -.
DR   HPA; HPA041113; -.
DR   MIM; 156491; gene.
DR   neXtProt; NX_P22392; -.
DR   OpenTargets; ENSG00000011052; -.
DR   OpenTargets; ENSG00000243678; -.
DR   PharmGKB; PA162398077; -.
DR   eggNOG; KOG0888; Eukaryota.
DR   eggNOG; COG0105; LUCA.
DR   GeneTree; ENSGT00760000119146; -.
DR   HOGENOM; HOG000224564; -.
DR   HOVERGEN; HBG000423; -.
DR   InParanoid; P22392; -.
DR   KO; K00940; -.
DR   PhylomeDB; P22392; -.
DR   TreeFam; TF106373; -.
DR   BioCyc; MetaCyc:HS04463-MONOMER; -.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P22392; -.
DR   SIGNOR; P22392; -.
DR   ChiTaRS; NME2; human.
DR   EvolutionaryTrace; P22392; -.
DR   GeneWiki; NME1-NME2; -.
DR   GeneWiki; NME2; -.
DR   PRO; PR:P22392; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000243678; -.
DR   ExpressionAtlas; P22392; baseline and differential.
DR   Genevisible; P22392; HS.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005882; C:intermediate filament; IEA:Ensembl.
DR   GO; GO:0030027; C:lamellipodium; IDA:HGNC.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0001726; C:ruffle; IDA:HGNC.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0005504; F:fatty acid binding; IEA:Ensembl.
DR   GO; GO:0019215; F:intermediate filament binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0004673; F:protein histidine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; TAS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:HGNC.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0006241; P:CTP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006183; P:GTP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:HGNC.
DR   GO; GO:0002762; P:negative regulation of myeloid leukocyte differentiation; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0030819; P:positive regulation of cAMP biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:HGNC.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IMP:HGNC.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0051259; P:protein oligomerization; IEA:Ensembl.
DR   GO; GO:0045682; P:regulation of epidermis development; IMP:HGNC.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0060416; P:response to growth hormone; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006228; P:UTP biosynthetic process; IEA:Ensembl.
DR   HAMAP; MF_00451; NDP_kinase; 1.
DR   InterPro; IPR001564; Nucleoside_diP_kinase.
DR   InterPro; IPR023005; Nucleoside_diP_kinase_AS.
DR   Pfam; PF00334; NDK; 1.
DR   PRINTS; PR01243; NUCDPKINASE.
DR   SMART; SM00562; NDK; 1.
DR   PROSITE; PS00469; NDP_KINASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; ATP-binding;
KW   Cell projection; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; DNA-binding; Kinase; Magnesium;
KW   Metal-binding; Nucleotide metabolism; Nucleotide-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Transferase.
FT   CHAIN         1    152       Nucleoside diphosphate kinase B.
FT                                /FTId=PRO_0000137117.
FT   REGION        1     66       Interaction with AKAP13.
FT                                {ECO:0000269|PubMed:15249197}.
FT   ACT_SITE    118    118       Pros-phosphohistidine intermediate.
FT                                {ECO:0000269|PubMed:1851158}.
FT   BINDING      12     12       ATP.
FT   BINDING      60     60       ATP.
FT   BINDING      88     88       ATP.
FT   BINDING      94     94       ATP.
FT   BINDING     105    105       ATP.
FT   BINDING     115    115       ATP.
FT   VAR_SEQ       1      1       M -> MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLV
FT                                GLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMV
FT                                WEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRTM
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16442775}.
FT                                /FTId=VSP_036708.
FT   STRAND        6     11       {ECO:0000244|PDB:3BBB}.
FT   HELIX        13     17       {ECO:0000244|PDB:3BBB}.
FT   HELIX        21     31       {ECO:0000244|PDB:3BBB}.
FT   STRAND       34     41       {ECO:0000244|PDB:3BBB}.
FT   HELIX        45     51       {ECO:0000244|PDB:3BBB}.
FT   HELIX        53     55       {ECO:0000244|PDB:3BBB}.
FT   HELIX        61     68       {ECO:0000244|PDB:3BBB}.
FT   STRAND       73     80       {ECO:0000244|PDB:3BBB}.
FT   HELIX        83     91       {ECO:0000244|PDB:3BBB}.
FT   HELIX        96     98       {ECO:0000244|PDB:3BBB}.
FT   HELIX       104    108       {ECO:0000244|PDB:3BBB}.
FT   HELIX       112    114       {ECO:0000244|PDB:3BBC}.
FT   STRAND      117    119       {ECO:0000244|PDB:3BBB}.
FT   HELIX       123    133       {ECO:0000244|PDB:3BBB}.
FT   HELIX       136    138       {ECO:0000244|PDB:3BBB}.
FT   HELIX       147    150       {ECO:0000244|PDB:3BBB}.
SQ   SEQUENCE   152 AA;  17298 MW;  1A5C3F84D7AD272C CRC64;
     MANLERTFIA IKPDGVQRGL VGEIIKRFEQ KGFRLVAMKF LRASEEHLKQ HYIDLKDRPF
     FPGLVKYMNS GPVVAMVWEG LNVVKTGRVM LGETNPADSK PGTIRGDFCI QVGRNIIHGS
     DSVKSAEKEI SLWFKPEELV DYKSCAHDWV YE
//
